Graphite Bio is harnessing the unprecedented power of targeted DNA integration to cure serious diseases
Co-founded by academic pioneers in the fields of gene editing and gene therapy, Graphite Bio is a next-generation gene editing company focused on the development of best-in-disease therapies for patients suffering from serious genetic disorders and beyond. The company’s gene editing platform harnesses the power of CRISPR and natural DNA repair processes to achieve highly efficient targeted DNA integration to precisely repair genetic defects at their source.
Our approach overcomes past limitations of gene editing, with the potential to improve the precision and efficiency of gene correction and insertion.
Our name is rooted in DNA discovery and embodies our singular purpose of fulfilling the unlimited potential of gene editing to improve human health.
At Graphite Bio, bold ideas, bright minds and a collaborative culture are brought together with the aim of changing patients’ lives.